Xie Jian 4
4 · Fulgent Genetics, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Fulgent Genetics (FLGT) President/COO Xie Jian Sells Shares
What Happened
Xie Jian, President and COO of Fulgent Genetics (FLGT), sold 2,146 shares on June 2, 2026, for total proceeds of $38,382. The reported weighted-average sale price was $17.89. The filing states the shares were sold to satisfy tax withholding obligations arising from the vesting of restricted stock units granted February 25, 2025.
Key Details
- Transaction date: 2026-06-02; filing date: 2026-06-03 (filed next day, appears timely).
- Sale type/code: Open market/private sale (S).
- Shares sold: 2,146; weighted-average price: $17.89; total proceeds: $38,382.
- Price range: sales executed in multiple transactions at $17.63–$18.10; reported price is the weighted average. Reporting person offered to provide per-transaction details on request.
- Reason per footnote: sale to satisfy tax withholding on vested RSUs (grant originally reported 2025-02-27).
- Shares owned after transaction: not disclosed on this Form 4.
- Additional note: footnote indicates certain securities are held by The Hsieh Family Dynasty Trust; Mr. Xie serves on its investment committee and disclaims beneficial interest except for any pecuniary interest.
Context
This appears to be a routine tax-withholding sale tied to RSU vesting rather than an independent directional trade. Such withholding sales are common and do not necessarily indicate the insider’s view on the company’s outlook.
Insider Transaction Report
Form 4
Xie Jian
President and COO
Transactions
- Sale
Common Stock
[F1][F2]2026-06-02$17.89/sh−2,146$38,382→ 367,605 total
Holdings
- 220,816(indirect: By Trust)
Common Stock
[F3]
Footnotes (3)
- [F1]The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.
- [F2]The shares were sold in multiple transactions at prices ranging from $17.63 to $18.10, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
Signature
/s/ Paul Kim as Attorney-in-Fact|2026-06-03